Flexuron
The ingredient used by the manufacturer of Flexuron is a type of DMAE. This drug is known to be a prostate enlargement treatment and was banned by the FDA due to the numerous reports of dangerous side effects. Read more at flexuron The American patent for this medicine contains an incorrect statement regarding the amount of active ingredient it contains. The patent refers to a low amount of the compound, but actually this product contains about 75% of the compound already used in many other products. There is an unnecessary negative reference in the patent. The FDA has reported cases of heart attack, liver problems, lung problems, nerve problems, and more. The manufacturer may have included the side effects in their product, as well as positive testimonies of how the product has been used. A former employee of the manufacturer also reported that the product has never been used in clinical trials and was not approved by the FDA. The product is still being manufactured today